New injection trial aims to protect insulin cells in type 1 diabetes

This study is testing whether regular injections of an experimental drug called OPT101 can help preserve the body's own insulin production in adults recently diagnosed with type 1 diabetes. Researchers will give the drug to 72 participants for up to one year to see if it's safe and if it helps maintain levels of C-peptide, a marker of insulin production. The goal is to see if this treatment can help control the disease by protecting remaining insulin-making cells.